AbbVie Stock Plummets to Second Place in Trading Volume Despite Weight Loss Market Entry

AbbVie Inc. (ABBV) closed at $210.01 on March 24, 2025, with a trading volume of $15.47 billion, down 55.84% from the previous day. The stock has been on a downward trend for five consecutive days, with a total decline of 2.47% over the past five days.

AbbVie's recent entry into the weight loss market has significantly boosted its stock performance. The company's announcement has driven its stock to trade near an all-time high, reflecting investor confidence in its new market strategy. This move aligns with the bullish trend observed in ABBV stock, which has shown strong performance since the beginning of the year.

Several institutional investors have recently adjusted their holdings in AbbVie, indicating a growing interest in the company's prospects. This includes Vanguard Group Inc., which has increased its stock holdings, and other hedge funds that have made similar modifications. The increased institutional investment suggests a positive outlook for AbbVie's future performance.